Literature DB >> 9707273

The cardiovascular dysmetabolic syndrome.

T C Fagan1, P C Deedwania.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9707273     DOI: 10.1016/s0002-9343(98)00216-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  13 in total

Review 1.  Hypertension and lipids: lipid factors in the hypertension syndrome.

Authors:  Gary E Sander; Thomas D Giles
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

Review 2.  Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study.

Authors:  S E Fineberg
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

3.  Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey.

Authors:  Richard F Gillum
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

4.  Relationship between body weight, quality of life and cardiovascular risk factors: a general population based Italian experience.

Authors:  F Baiardi; M G Puglia; G Valpiani; A Sturani; C Baraccani; M Gentile; A R Cassani; M Di Stani; E Degli Esposti
Journal:  Eat Weight Disord       Date:  2005-03       Impact factor: 4.652

Review 5.  Mechanisms of endothelial dysfunction in the metabolic syndrome.

Authors:  Prakash C Deedwania
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

6.  Significant association of metabolic syndrome with silent brain infarction in elderly people.

Authors:  Hyung-Min Kwon; Beom Joon Kim; Jin-Ho Park; Wi-Sun Ryu; Chi-Kyung Kim; Su-Ho Lee; Sang-Bae Ko; Hyunwoo Nam; Seung-Hoon Lee; Yong-Seok Lee; Byung-Woo Yoon
Journal:  J Neurol       Date:  2009-06-16       Impact factor: 4.849

Review 7.  Metabolic and additional vascular effects of thiazolidinediones.

Authors:  Fabrice M A C Martens; Frank L J Visseren; Jacinthe Lemay; Eelco J P de Koning; Ton J Rabelink
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions.

Authors:  R Bigi; L Cortigiani; P Colombo; A Desideri; J J Bax; O Parodi
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 9.  What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.

Authors:  Sean Carroll; Mike Dudfield
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  Clinical significance of cardiovascular dysmetabolic syndrome.

Authors:  Prakash C Deedwania
Journal:  Curr Control Trials Cardiovasc Med       Date:  2002-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.